secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001493152-24-005029
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa regains Nasdaq minimum bid price compliance; delisting risk resolved
-----------------------------------------------------------------------------

- Received written notice from Nasdaq on Feb 6, 2024 confirming compliance with Listing Rule 5550(a)(2).
- Achieved minimum $1.00 closing bid price for 10 consecutive business days ending Feb 2, 2024.
- Matter is now closed; no further deficiency or delisting action pending.
- Stock ticker PCSA; compliance removal removes immediate delisting overhang.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224005029/0001493152-24-005029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224005029/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-005029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer